Viking Therapeutics Inc. (0VQA)
Market Closed
16 Oct, 03:30 PM
$
25. 27
-1.62
-6.0245%
$
- Market Cap
- P/E Ratio
- Div Yield
12,132 Volume
-0.92 Eps
$ 26.89
Previous Close Want to track 0VQA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Viking Therapeutics Inc. (0VQA) Statistics
Valuation metrics
Market Cap -
Enterprise value 3.08B
Trailing P/E (ttm) -5.4
Forward P/E -
PEG ratio 0.07
Price/Sales (ttm) -
Price/Book (mrq) 7.15
Enterprise Value/Revenue -
Enterprise Value/EBITDA -5.76
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 19.22K
Average volume (90 days) 21.05K
Price summary
52-Week low 25.23
52-Week high 45.9
Beta -
50-Day moving average 31.34
200-Day moving average 32.98
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.02%
Return on equity -0.95%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -4.61
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.33
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 4.72%
Book value per share (mrq) 3.52
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
